Vacunas

CORONAVAC

VER ENLACES DE LAS PUBLICACIONES

• Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile. Clin Infect Dis. 2022 Aug 24;75(1):e792-e804
• SafetyandNon-InferiorityEvaluationofTwoImmunizationScheduleswith anInactivatedSARS-CoV-2Vaccine inAdults:ARandomizedClinicalTrial. Vaccines (Basel). 2022 Jul 6;10(7):1082.
• Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial. medRxiv [Preprint]. 2021 Apr 1:2021.03.31.21254494.
• Update in: Clin Infect Dis. 2022 Aug 24;75(1):e792-e804.

PEDCORONAVAC

VER ENLACE DE LA PUBLICACIÓN

• Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.mBio. 2022 Dec 20;13(6):e0131122.

TETRAFLUVAC

CORONAVAR

VER ENLACE DE LA PUBLICACIÓN

• A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern. mBio. 2022 Aug 30;13(4):e0142322

STRIDE 13